Page last updated: 2024-12-06
girolline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
girolline: has antineoplastic activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 362388 |
| CHEMBL ID | 1982734 |
| SCHEMBL ID | 9862352 |
| MeSH ID | M0518433 |
Synonyms (11)
| Synonym |
|---|
| nsc626159 |
| nsc-626159 |
| girolline |
| 1h-imidazole-4-methanol, 2-amino-.alpha.-(2-amino-1- chloroethyl)- |
| NCI60_008277 |
| 3-amino-1-(2-amino-1h-imidazol-5-yl)-2-chloropropan-1-ol |
| SCHEMBL9862352 |
| CHEMBL1982734 |
| girolline; rp 49532 |
| Q15634136 |
| DTXSID00869538 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||